The most highly cited study for lung cancer related radiosensitizer publications was “Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine”, published by Sarkaria JN and Abraham, RT in Cancer Research in 1999 with 946 citations to date. The gene discussed is ATM; the disease is cancer.